Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dexamethasone suppression test in depression with reversible dementia.

G S Alexopoulos, R C Young, J A Haycox

    Psychiatry Research
    |December 1, 1985
    PubMed
    Summary

    The 1-mg dexamethasone suppression test (DST) shows similar abnormal rates in elderly patients with primary degenerative dementia and major depression. An abnormal DST does not predict dementia outcome in depressed patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Publisher Correction: Brain charts for the human lifespan.

    Nature·2022
    Same author

    Brain charts for the human lifespan.

    Nature·2022
    Same author

    Physical Exercise for Late-Life Major Depression.

    Focus (American Psychiatric Publishing)·2021
    Same author

    Stabilization treatment of remitted psychotic depression: the STOP-PD study.

    Acta psychiatrica Scandinavica·2018
    Same author

    Physical exercise for late-life major depression.

    The British journal of psychiatry : the journal of mental science·2015
    Same author

    Cognitive control, reward-related decision making and outcomes of late-life depression treated with an antidepressant.

    Psychological medicine·2015

    Area of Science:

    • Geriatric Psychiatry
    • Neuroendocrinology
    • Cognitive Neurology

    Background:

    • Depression with reversible dementia is common in the elderly, posing diagnostic challenges.
    • The dexamethasone suppression test (DST) is used to assess hypothalamic-pituitary-adrenal axis function.
    • Distinguishing between depression-related cognitive impairment and primary dementia is clinically significant.

    Purpose of the Study:

    • To evaluate the utility of the 1-mg dexamethasone suppression test (DST) in elderly psychiatric patients.
    • To investigate the relationship between abnormal DST results and different forms of cognitive dysfunction in depression.
    • To determine if DST results can predict the outcome of dementia in depressed individuals.

    Main Methods:

    • The 1-mg DST was administered to 175 elderly psychiatric patients.

    Related Experiment Videos

  • Patients were categorized into groups: primary degenerative dementia, major depression without cognitive dysfunction, and depression with reversible dementia.
  • Incidence of abnormal DSTs was compared across patient groups.

    • Main Results:

    • Abnormal DSTs were observed in 34.9% of patients with primary degenerative dementia and 66.1% of those with major depression without cognitive dysfunction.
    • No significant difference in abnormal DST incidence was found among depressed patients with reversible dementia (78.6%), cognitively intact depressives (66.2%), and those with co-occurring primary degenerative dementia (70.8%).
    • These findings suggest shared hypothalamic abnormalities in primary dementia and depression.

    Conclusions:

    • The 1-mg DST is not clinically useful for predicting dementia outcomes in depressed elderly patients with cognitive dysfunction.
    • Abnormal DST results may indicate common underlying hypothalamic dysregulation in elderly depression and dementia.
    • Further research is needed to understand the neurobiological links between depression and dementia in older adults.